drugset / Trial / NCT00412555

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

NCT00412555

Phase 4 Completed 52 enrolled Hoffmann-La Roche
Non-randomizedSingle-groupOpen-labelPrevention

Summary

This study will evaluate the safety of Tamiflu, when used for the prevention of influenza in children during the flu season. Children who would benefit from influenza prophylaxis when influenza is circulating in the community will receive treatment with Tamiflu syrup (or capsules) 30mg-75mg once daily (dependent on body weight) for 6 weeks. Safety data and influenza symptoms will be recorded throughout the study. The anticipated time on study treatment is \<3 months, and the target sample size is \<100 individuals.

Timeline

Start
2006-12
Primary completion
2007-05
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Oseltamivir Small molecule 30 mg Oral
Subject Oseltamivir Small molecule 75 mg Oral

Indications